SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cadila Healthcare
Cadila Healthcare
BSE: 532321|NSE: CADILAHC|ISIN: INE010B01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 19, 16:30
1515.95
-21 (-1.37%)
VOLUME 5,144
LIVE
NSE
Dec 19, 16:30
1513.50
-21.6 (-1.41%)
VOLUME 49,476
News on Cadila Healthcare
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Cadila Healthcare; target of Rs 1715: Firstcall

3.47 pm | 19 Dec 2014 |  Source: Moneycontrol.com

Brokerage house Firstcall Research is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target price of Rs 1715 in its r...

India caps prices of 52 more 'essential' drugs: NPPA

2.42 pm | 12 Dec 2014 |  Source: Reuters

INDIA-PHARMACEUTICALS-PRICES:India caps prices of 52 more "essential" drugs - NPPA...

Valuations high; US may slow if oil dips further: Tandon 

9.11 am | 10 Dec 2014 |  Source: CNBC-TV18

At the moment, the environment is such that valuations are still high and no economic recovery has been seen on the growth. At the same time, fund flo...

Nod by international regulators key for Cadila: Dandekar 

4.35 pm | 09 Dec 2014 |  Source: CNBC-TV18

Getting an approval for the product for all the four areas i.e, ankylosing spondylitis, rheumatoid arthritis, juvenile idiopathic arthritis, and psori...

We try to launch products at one-fifth global price: Cadila 

3.44 pm | 09 Dec 2014 |  Source: CNBC-TV18

Zydus Cadila launched the biosimilar version of Adalimumab, which is the world's first biosimilar made end-to-end in India. Sharvil Patel, Deputy MD, ...

Zydus launches world's first biosimilar of Adalimumab

12.14 pm | 09 Dec 2014 |  Source: Moneycontrol.com

Zydus Cadila becomes the first company anywhere in the world to launch the biosimilar of Adalimumab – the world’s largest selling therapy....

Here are top 10 stocks to focus on December 9 

8.50 am | 09 Dec 2014 |  Source: CNBC-TV18

Here are top 10 stocks to keep an eye on December 9 - Idea Cellular, Opto Circuits, Karnataka Bank, Sun Pharma, Ranbaxy, Spicejet, OnMobile Global, Ba...

Cadila recalls 15,144 bottles of hypertension drug in US

8.38 am | 09 Dec 2014 |  Source: PTI

As per information available on the USFDA website, Zydus Pharmaceuticals USA Inc, the US-based arm of the company, is recalling the drug due to "disco...

Stocks in news: Sun Pharma, Ranbaxy, ITC, Cadila, OnMobile

8.15 am | 09 Dec 2014 |  Source: CNBC-TV18

Sun Pharma | Ranbaxy Labs | ONGC | Tata Motors | ICICI Bank | ITC | Sterlite Technologies | Cadila Healthcare | SpiceJet | Opto Circuits | OnMobile Gl...

Cadila recalls 15,144 bottles of hypertension drug in US

9.14 pm | 08 Dec 2014 |  Source: PTI

The nationwide recall has been initiated by the company on October 1 this year and has been initiated under Class-III which FDA defined as "a situatio...

Accumulate Cadila Healthcare; target of Rs 1480: KRChoksey

12.09 pm | 14 Nov 2014 |  Source: Moneycontrol.com

KRChoksey is bullish on Cadila Healthcare and has recommended accumulate rating on the stock with a target price of Rs 1480 in its November 07, 2014 r...

FDA warns Cadila Pharma over drug production processes

12.42 pm | 12 Nov 2014 |  Source: Reuters

Cadila Pharmaceuticals is the latest Indian drugmaker to face US regulatory rebuke, as the FDA intensifies its scrutiny of the generic drugmakers....

Cadila Healthcare Q2 net up 52% at Rs 278 crore

1.46 pm | 06 Nov 2014 |  Source: PTI

The company had posted a net profit after taxes, minority interest and share in profit/(loss) of associates at Rs 183.37 crore for the corresponding p...

Buy Cadila Healthcare; tgt of Rs 1410: Firstcall Research

1.14 pm | 01 Oct 2014 |  Source: Moneycontrol.com

Firstcall Research is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target of Rs 1410 in its September 26, 2014 rese...

Accumulate Cadila Healthcare; target of Rs 1220: KRChoksey

6.29 pm | 12 Aug 2014 |  Source: Moneycontrol.com

KRChoksey is bullish on Cadila Healthcare and has recommended accumulate rating on the stock with a target of Rs 1220 in its July 31, 2014 research re...

Hold Cadila Healthcare; target of Rs 1300: Sharekhan

11.59 am | 05 Aug 2014 |  Source: Moneycontrol.com

Sharekhan has recommended a hold rating on Cadila Healthcare with a target price of Rs 1300 per share in its July 30, 2014 research report....

Buy Cadila Healthcare; target of Rs 1205: Motilal Oswal

6.05 pm | 01 Aug 2014 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target of Rs 1205 in its July 30, 2014 research repor...

Accumulate Cadila Healthcare; tgt of Rs 1309: Dolat Capital

4.22 pm | 01 Aug 2014 |  Source: Moneycontrol.com

Dolat Capital is bullish on Cadila Healthcare and has recommended accumulate rating on the stock with a target of Rs 1309 in its July 30, 2014 researc...

Hold Cadila Healthcare; target of Rs 1059: ICICIdirect

1.44 pm | 01 Aug 2014 |  Source: Moneycontrol.com

ICICIdirect.com has recommended hold rating on Cadila Healthcare with a target price of Rs 1059, in its research report dated July 31, 2014....

Dr Reddy's, Lupin, Glenmark top pharma bets: Nomura 

11.25 am | 31 Jul 2014 |  Source: CNBC-TV18

"We have a buy recommendation on both Sun Pharma and Ranbaxy at this point," Saion Mukherjee, research analyst Nomura said....

1 2 3
Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.